Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Cumulative percentages of all-cause mortality (top), sudden death (middle) and hospitalizations for worsening heart failure (bottom). Low-dose metoprolol controlled-release/extended-release (CR/XL) subgroup is illustrated in the left hand panel and high-dose metoprolol CR/XL group in the right hand panel (Cox-adjusted estimates. Estimates of risk have been obtained from the fitted models explaining why the graphs for the placebo groups have a different appearance in the low- and high-dose subgroups; see Statistical Methods section).





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement